Avail Clinical Research Announces Hepatitis C Research Studies in DeLand, FL

March 3, 2010 - PRLog -- DeLand, Florida— Avail Clinical Research, a privately owned research facility, founded in 1998 in DeLand, FL, announces the launch of several research studies to test investigational treatment options for those already diagnosed with hepatitis C. “We are very pleased to begin the systemic evaluation of our research studies to help find a viable investigational treatment solution to those suffering from hepatitis C,” said Bruce G. Rankin, DO, CPI., the Vice Chief of Medicine at Florida Hospital DeLand. “We believe that these research studies will build significantly on the data generated by other studies conducted on investigational treatment options for hepatitis C." Dr. Rankin has been conducting research with Avail Clinical Research since 1999 and is currently the Medical Director.

The research studies will enroll those already diagnosed with hepatitis C, which includes symptoms like fatigue, fever, nausea or poor appetite, muscle and joint pains, tenderness in the area of your liver. In order to participate in the studies volunteers must be diagnosed with hepatitis C. Avail Clinical Research will not take volunteers who:

·have any evidence or treatment of malignancy within the previous 5 years,

·have a history of alcohol or substance abuse within the previous 5 years,

·have used an investigatory drug or participated in an investigatory study within 30 days of the screening,

·are pregnant, or

·are breast-feeding.

Avail Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications. Participants will also be compensated for time and travel. For more information regarding participation in our research studies, contact Avail Clinical Research at 386.310.1334, or at www.AvailClinical.com.

# # #

Avail Clinical Research is currently conducting a wide array of clinical studies targeted towards certain conditions. You may be eligible to participate in one of our clinical trials and contribute to the development and approval of a new drug or treatment. As a participant, there is no cost to you at any point during the study and health insurance is not required. Browse our clinical trials being conducted now to find the study best suited for you.